News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 697 2141

Jazz Pharmaceuticals to Report 2021 Third Quarter Financial Results on November 9, 2021

October 26, 2021

DUBLIN, Oct. 26, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 third quarter financial results on Tuesday, November 9, 2021 after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET/9:30 p.m. IST to discuss 2021 third quarter financial results and provide a business and financial update. 

Audio webcast/conference call:
U.S. Dial-In Number: +1 855 353 7924
International Dial-In Number: +1 503 343 6056
Passcode: 5888822

A replay of the conference call will be available through November 16, 2021.

Replay U.S. Dial-In Number: +1 855 859 2056
Replay International Dial-In Number: +1 404 537 3406
Passcode: 5888822

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Jazz Pharmaceuticals Contacts:


Investors: 
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations

Jazz Pharmaceuticals plc
investorinfo@jazzpharma.com

Ireland, +353 1 634 3211

U.S., +1 650 496 2717

Media:
Kristin Bhavnani

Head of Global Corporate Communications

Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com

Ireland, +353 1 697 2141

U.S., +1 215 867 4948

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-2021-third-quarter-financial-results-on-november-9-2021-301408999.html

SOURCE Jazz Pharmaceuticals plc